Related Experiment Video
Updated: Aug 16, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Paclitaxel induces apoptosis via caspase-3 activation in human osteogenic sarcoma cells (U-2 OS)
1Department of Orthopaedic Surgery, Chung Shan Medical University Hospital, Taichung 402, Taiwan, ROC.
Abstract:
Paclitaxel has been found to exhibit cytotoxic and antitumor activity. There is little information regarding the mechanisms of apoptotic-inducing effect of paclitaxel on human osteogenic sarcoma U-2 OS cells. Several key regulatory proteins are involved in the initiation of apoptosis. Caspase-3 plays a direct role in proteolytic cleavage of cellular proteins responsible for progression to apoptosis. We examined the effect of paclitaxel on the cell cycle arrest and apoptosis in U-2 OS cells using flow cytometric analysis and Western blotting. We also measured the inhibition of paclitaxel-induced apoptosis and the caspase-3 activity by the broad-spectrum caspase inhibitor z-VAD-fmk on U-2 OS cells. The increased levels of casapse-3 were also confirmed by cDNA microarray. Our observations were: (1) paclitaxel treatment resulted in G2/M-cycle arrest in U-2 OS cells; (2) time and dose dependent apoptosis of U-2 OS cells was induced by paclitaxel; (3) in U-2 OS cells, z-VAD-fmk blocked the paclitaxel-induced apoptosis and caspase-3 activation. These results suggest that paclitaxel-induced G2/M-cycle arrest of the G2/M phase and apoptosis via a caspase-3 pathway in U-2 OS cells.
Insights
Paclitaxel induces G2/M cell cycle arrest and apoptosis in osteosarcoma U-2 OS cells. This process is mediated by caspase-3 activation, a key protein in programmed cell death.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Paclitaxel demonstrates cytotoxic and antitumor properties.
- The precise mechanisms of paclitaxel-induced apoptosis in human osteosarcoma U-2 OS cells remain incompletely understood.
- Apoptosis initiation involves key regulatory proteins, including caspase-3, which executes programmed cell death.
Purpose of the Study:
- To investigate the effects of paclitaxel on cell cycle progression and apoptosis in U-2 OS cells.
- To elucidate the role of caspase-3 in paclitaxel-mediated apoptosis in this cell line.
- To confirm caspase-3 involvement using a broad-spectrum caspase inhibitor.
Main Methods:
- Flow cytometric analysis was employed to assess cell cycle distribution.
- Western blotting was utilized to evaluate protein expression levels.
- cDNA microarray analysis confirmed caspase-3 expression.
- The impact of the caspase inhibitor z-VAD-fmk on paclitaxel-induced effects was examined.
Main Results:
- Paclitaxel treatment led to a significant G2/M phase cell cycle arrest in U-2 OS cells.
- Paclitaxel induced apoptosis in a time- and dose-dependent manner.
- The caspase inhibitor z-VAD-fmk effectively blocked paclitaxel-induced apoptosis and caspase-3 activation in U-2 OS cells.
- Increased caspase-3 levels were confirmed via cDNA microarray.
Conclusions:
- Paclitaxel induces G2/M cell cycle arrest in human osteosarcoma U-2 OS cells.
- Apoptosis triggered by paclitaxel in U-2 OS cells is dependent on the caspase-3 pathway.
- These findings highlight paclitaxel's potential as a therapeutic agent targeting osteosarcoma through caspase-3-mediated apoptosis.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Caspases
The Extrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
